Hochschulschrift
Characterization of murine pancreatic carcinoma models regarding immunosuppressive mechanisms and therapy with bifunctional siRNA targeting galectin-1
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Diss., 2014
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2014
- Urheber
-
Adunka, Tina
- Beteiligte Personen und Organisationen
-
Schnurr, Max
- URN
-
urn:nbn:de:bvb:19-174491
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-03-25T13:53:06+0100
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Adunka, Tina
- Schnurr, Max
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2014
Ähnliche Objekte (12)
Role of galectin-1 and galectin-3 in the interaction of pancreatic stellate cells and pancreatic tumor cells
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels : = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas
Immunosuppressive Leberfaktoren : experimentelle Studien
Bifunctional molecular catalysis
Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
Heteromultivalente Glykomakromoleküle Targeting Galectin-3
Antineoplastic and immunosuppressive agents, T. 1.
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
Design and characterization of galectin-3 fusion proteins and novel multivalent galectin-3 ligands
Targeted antitumoral siRNA delivery
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
Role of galectin-1 and galectin-3 in the interaction of pancreatic stellate cells and pancreatic tumor cells
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels : = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas
Immunosuppressive Leberfaktoren : experimentelle Studien
Bifunctional molecular catalysis
Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
Heteromultivalente Glykomakromoleküle Targeting Galectin-3
Antineoplastic and immunosuppressive agents, T. 1.
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
Design and characterization of galectin-3 fusion proteins and novel multivalent galectin-3 ligands
Targeted antitumoral siRNA delivery
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
Role of galectin-1 and galectin-3 in the interaction of pancreatic stellate cells and pancreatic tumor cells
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3
Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels : = Die Rolle von Galectin-9 im duktalen Adenokarzinom des Pankreas
Immunosuppressive Leberfaktoren : experimentelle Studien
Bifunctional molecular catalysis
Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
Heteromultivalente Glykomakromoleküle Targeting Galectin-3
Antineoplastic and immunosuppressive agents, T. 1.
Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma
Design and characterization of galectin-3 fusion proteins and novel multivalent galectin-3 ligands
Targeted antitumoral siRNA delivery